Skip to main content
Equibles
AFJK logo

AFJK · Aimei Health Technology Co., Ltd. · Metrics

Track AFJK — free

Use AFJK with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research AFJK.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$12.20 -0.01 (-0.08%) At close · Nov 6
Rebalance outlook locked
Going-concern doubt — flagged Aug 13, 2026

Substantial doubt about the company's ability to continue as a going concern.

“In connection with the Company's assessment of going concern considerations in accordance with Accounting Standards Update ("ASU") 2014-15, "Disclosures of Uncertainties about an Entity's Ability to Continue as a Going Concern," management has determined that if the Company is unsuccessful in consummating an initial business combination within the prescribed period of time from the closing of the Initial Public Offering, the requirement that the Company cease all operations, redeem the Public Shares, and thereafter liquidate and dissolve raises substantial doubt about the ability to continue as a going concern within one year after the date that the unaudited financial statements are issued.”
View the 10-Q filed Aug 13, 2026
Market Cap
$38.63M
Shares
3.17M
Volume · Nov 6 1240 Avg daily vol (3M) 17.66K

AFJK metrics

48 of 125 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$12.20
Market cap
$38.63M

Price action

23 metrics
Price change (1W)
-2.8%
Price change (30D)
+0.7%
Price change (3M)
+2.2%
Price change (6M)
-73.1%
Price change (YTD)
-80.9%
Price change (1Y)
-9.9%
Trailing year
Price change (5Y)
—
52-week high
$88.50
52-week low
$8.00
Change from 52-week high
-86.2%
Change from 52-week low
+52.6%
Annualized volatility
1,080.6%
Annualized volatility (3M)
—
Implied volatility (30D)
—
IV rank (1Y)
—
IV percentile (1Y)
—
Beta
-1.7
RSI (14D)
48.3
Price vs SMA 50
+0.1%
Price vs SMA 200
-60.4%
Avg volume (3M)
17,834
Relative volume
0.8
Average dollar volume
$217,122

Company

3 metrics
Sector
Financial Services
Industry
Shell Companies
Shares outstanding
3.17M

Valuation

12 metrics
P / E (TTM)
93.7
Trailing earnings · reciprocal yield 1.1%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
—
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
1.1%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
—
Operating profit (TTM)
−$635,073
Net income (TTM)
$412,432
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
0.0%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-1.91

Growth

11 metrics
Revenue growth YoY
—
Year over year
Net income growth YoY
-119.6%
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
-48.3%
Year over year · fewer shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
—
Return on assets
3.3%
Debt / equity
—
Current ratio
0.0
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
0.0
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
—
Total assets
$12.53M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$370,854
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
21
13F filer change QoQ
0
Institutional ownership
151.5%
Conviction holders (share of 13F filers)
—
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
25.7%
Active holders' share change QoQ
0.0%
Holder tenure
9.4
Price vs estimated holder cost
+156.7%

Ownership (registered funds)

1 metrics
Index-fund ownership
0.0%

Short interest

3 metrics
Short interest
0.1%
Latest settlement · 1.6 days to cover
Days to cover
1.6d
Short-squeeze score
30 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
Flagged
Key facts CIK 1979005 CUSIP G01341109 13F (30d) 2 filings 2 filers